Skip to main content

Abbott Laboratories lowers outlook as demand for Covid-19 testing wanes, sending stock price down

Abbott Laboratories Inc. said Tuesday that it is lowering its earnings per share forecast for 2021 due to reduced demand for Covid-19 tests, which the company manufactures.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.